Meetings; Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 44035-44036 [2014-17739]

Download as PDF Federal Register / Vol. 79, No. 145 / Tuesday, July 29, 2014 / Notices enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Dated: July 15, 2014. Richard Kronick, AHRQ Director. BILLING CODE 4160–90–M [FR Doc. 2014–17737 Filed 7–28–14; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—Health Disparities Subcommittee (HDS) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: rmajette on DSK2TPTVN1PROD with NOTICES Time and Date 10:00 a.m.–11:30 a.m. EDT, August 19, 2014. PLACE: Teleconference. STATUS: This meeting is open to the public, limited only by the availability of telephone ports. The public is welcome to participate during the public comment period, which is tentatively scheduled from 11:20 to 11:30 a.m. To participate on the teleconference, please dial (866) 763– 0273 and enter code 6158968. PURPOSE: The Subcommittee will provide advice to the CDC Director through the ACD on strategic and other health disparities and health equity issues and provide guidance on opportunities for CDC. MATTERS FOR DISCUSSION: The Health Disparities Subcommittee (HDS) members will discuss progress to date on the recommendations approved by the CDC ACD in April 2014 and review updates on previously established priorities of the HDS. The agenda is subject to change as priorities dictate. Jkt 232001 Center Parkway, Atlanta, Georgia 30345, Telephone: (404) 498–6185. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Gary Johnson, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–17804 Filed 7–28–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention 15:02 Jul 28, 2014 Leandris Liburd, Ph.D., M.P.H., M.A., Designated Federal Officer, Health Disparities Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road NE., M/S K–77, Atlanta, Georgia 30333. Telephone (770) 488– 8182, Email: LEL1@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–17660 Filed 7–28–14; 8:45 am] VerDate Mar<15>2010 CONTACT PERSON FOR MORE INFORMATION: 44035 Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Meetings; Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns the NIOSH Assessment of Elastomeric Respirators in Healthcare Environments, RFA–OH–14–009, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date 1:00 p.m.–4:00 p.m., August 20, 2014 (Closed) PLACE: Teleconference STATUS: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. MATTERS FOR DISCUSSION: The meeting will include the initial review, discussion, and evaluation of applications received in response to the ‘‘NIOSH Assessment of Elastomeric Respirators in Healthcare Environments, RFA–OH–14–009.’’ CONTACT PERSON FOR MORE INFORMATION: Donald Blackman, Ph.D., Scientific Review Officer, CDC, 2400 Century PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 Time and Date 1:00–3:00 p.m. EDT, August 19, 2014 Place: Teleconference. Status: The meeting is open to the public; the toll free dial in number is 1– 877–951–7311 with a pass code of 7634914. Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters for Discussion: The following topics will be discussed: (1) reports back from the May 2014 BSC, OID, working group meetings and (2) an update from OID on recent outbreak responses and national center priorities. The agenda and any supplemental material will be available at www.cdc.gov/oid/BSC.html after August 10. E:\FR\FM\29JYN1.SGM 29JYN1 44036 Federal Register / Vol. 79, No. 145 / Tuesday, July 29, 2014 / Notices Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639– 4461. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–17739 Filed 7–28–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention rmajette on DSK2TPTVN1PROD with NOTICES Request for Nominations of Candidates To Serve on the Advisory Committee to the Director, Centers for Disease Control and Prevention The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC). This committee consists of 15 experts in fields related to health policy, public health, global health, preparedness, preventive medicine, the faith-based and community-based sector, and allied fields who are selected by the Secretary of the U.S. Department of Health and Human Services (HHS). The committee advises the HHS Secretary and the CDC Director concerning policy and broad strategies that will enable CDC to fulfill its mission of protecting health through health promotion, prevention, and preparedness. The committee recommends ways to prioritize CDC’s activities, improve results, and address health disparities. It also provides guidance to help CDC work more effectively with its various private and public sector constituents to make health protection a practical reality. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishment of the committee’s mission. Nominees will be selected by the HHS Secretary or designee from VerDate Mar<15>2010 15:02 Jul 28, 2014 Jkt 232001 authorities knowledgeable in the fields of public health as well as from the general public. Members may be invited to serve for terms of up to four years. The U.S. Department of Health and Human Services policy stipulates that committee membership shall be balanced in terms of professional training and background, points of view represented, and the committee’s function. In addition to a broad range of expertise, consideration is given to a broad representation of geographic areas within the U.S., with diverse representation of both genders, ethnic and racial minorities, lesbian, gay, bisexual, and transgender and persons with disabilities. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: • Current curriculum vitae, including complete contact information (name, affiliation, mailing address, telephone number, email address); • A letter of recommendation stating the qualifications of the candidate. Nomination materials must be postmarked by August 31, 2014, and sent to: Gayle Hickman, Office of the Chief of Staff, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop D14, Atlanta, Georgia 30333, telephone (404) 639– 7158. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–17736 Filed 7–28–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Notice of Hearing: Reconsideration of Disapproval; Louisiana Medicaid State Plan Amendments (SPAs) 13–23, 13–25 and 13–28 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice of Hearing: Reconsideration of Disapproval. AGENCY: PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 This notice announces an administrative hearing to be held on September 9, 2014, at the Department of Health and Human Services, Centers for Medicare & Medicaid Services, Division of Medicaid & Children’s Health, Dallas Regional Office, 1301 Young Street, Room #801, 8th Floor Dallas, Texas 75202 to reconsider CMS’ decision to disapprove Louisiana’s Medicaid SPAs 13–23, 13–25 and 13–28. Closing Date: Requests to participate in the hearing as a party must be received by the presiding officer by August 13, 2014. FOR FURTHER INFORMATION CONTACT: Benjamin R. Cohen, Presiding Officer, CMS, 2520 Lord Baltimore Drive, Suite L, Baltimore, Maryland 21244, Telephone: (410) 786–3169. SUPPLEMENTARY INFORMATION: This notice announces an administrative hearing to reconsider CMS’ decision to disapprove the Louisiana Medicaid SPAs 13–23, 13–25 and 13–28. CMS received Louisiana SPAs 13–23 and 13– 25 on June 27, 2013, and 13–28 on July 12, 2013 with proposed effective dates of June 24, 2013 and October 1, 2013, respectively. The amendments propose to provide for supplemental Medicaid inpatient hospital payments and disproportionate share hospital (DSH) payments to private hospitals participating in public-private partnerships. These SPAs were disapproved on May 2, 2014. The issues to be considered at the hearing are: • Whether the state established that Louisiana SPAs 13–23, 13–25 and 13–28 comply with section 1903(w) of the Social Security Act (the Act) which generally provides that state expenditures are not allowable to the extent that the state receives certain provider-related donations and taxes As set forth in implementing regulations at 42 Code of the Federal Register (CFR) 433.54, expenditures are not allowable, and federal financial participation (FFP) is not available, to the extent that the state receives provider-related donations and there is a ‘‘hold harmless arrangement’’ under which providers (or the provider class) could be effectively repaid for a provider-related tax or donation through any direct or indirect payment, offset, or waiver. Æ Specifically, at issue is whether (1) the state established that certain payments from providers to the state (characterized by the state as advance lease payments) were not provider donations, when the state did not document such payments to be consistent with ordinary market business practices for leasing property; SUMMARY: E:\FR\FM\29JYN1.SGM 29JYN1

Agencies

[Federal Register Volume 79, Number 145 (Tuesday, July 29, 2014)]
[Notices]
[Pages 44035-44036]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17739]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meetings; Board of Scientific Counselors, Office of Infectious 
Diseases (BSC, OID)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

Time and Date

1:00-3:00 p.m. EDT, August 19, 2014
    Place: Teleconference.
    Status: The meeting is open to the public; the toll free dial in 
number is 1-877-951-7311 with a pass code of 7634914.
    Purpose: The BSC, OID, provides advice and guidance to the 
Secretary, Department of Health and Human Services; the Director, CDC; 
the Director, OID; and the Directors of the National Center for 
Immunization and Respiratory Diseases, the National Center for Emerging 
and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: 
strategies, goals, and priorities for programs; research within the 
national centers; and overall strategic direction and focus of OID and 
the national centers.
    Matters for Discussion: The following topics will be discussed: (1) 
reports back from the May 2014 BSC, OID, working group meetings and (2) 
an update from OID on recent outbreak responses and national center 
priorities.
    The agenda and any supplemental material will be available at 
www.cdc.gov/oid/BSC.html after August 10.

[[Page 44036]]

    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Robin Moseley, M.A.T., 
Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop 
D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-17739 Filed 7-28-14; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.